Indication
Mixed Hyperlipemia
1 clinical trial
1 product
Product
SHR-1209Clinical trial
Phase III, Multicentre, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of SHR-1209 Monotherapy in Patients With Primary Hypercholesterolemia and Mixed HyperlipemiaStatus: Completed, Estimated PCD: 2022-06-21